Thomas Kodadek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Kodadek has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Devanjan Sikder
Departments of Internal Medicine, Molecular Biology and Microbiology, University of Texas Southwestern Medical Center a , 5323 Harry Hines Blvd, Dallas, TX 75390-9185, USA
7 shared publicationsPeng Yu
7 shared publicationsXiangshu Xiao
Departments of Internal Medicine and Molecular Biology, Division of Translational Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9185
6 shared publicationsBo Liu
Department of Internal Medicine, Division of Translational Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA
5 shared publicationsChase T. Archer
Division of Translational Research and Department of Internal Medicine, University of Texas-Southwestern Medical Center, Dallas, TX 75390-9185, USA
5 shared publicationsHyun-Suk Lim
Department of Internal Medicine, Division of Translational Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9185, USA
5 shared publications
Latest Publications
- 17 July 2009
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (15) , 4604-4612
Investigation of the Relative Cellular Permeability of DNA-Binding Pyrrole−Imidazole Polyamides
Pyrrole−imidazole (Py-Im) polyamides are a group of chemicals that are able to bind specifically to DNA sequences in vitro and in mammalian cells. Using a cell based reporter assay, we investigated the size and linker affects on the cellular permeability of polyamides. We found that the conventional β-alanine-3,3′-diamino-N-methyldipropylamine (βDa) linker strongly limited the cellular permeability. We discovered that a short ethylene diamine (Et) linker displayed high cellular permeability. With the improved Et linker, we found that the cellular permeability of polyamides was size-dependent.
- 17 July 2009
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (15) , 4604-4612
Investigation of the Relative Cellular Permeability of DNA-Binding Pyrrole−Imidazole Polyamides
Pyrrole−imidazole (Py-Im) polyamides are a group of chemicals that are able to bind specifically to DNA sequences in vitro and in mammalian cells. Using a cell based reporter assay, we investigated the size and linker affects on the cellular permeability of polyamides. We found that the conventional β-alanine-3,3′-diamino-N-methyldipropylamine (βDa) linker strongly limited the cellular permeability. We discovered that a short ethylene diamine (Et) linker displayed high cellular permeability. With the improved Et linker, we found that the cellular permeability of polyamides was size-dependent.
- 1 July 2009
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (14) , 3866-3869
Rapid identification of improved protein ligands using peptoid microarrays
- 1 July 2009
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (14) , 3866-3869
Rapid identification of improved protein ligands using peptoid microarrays
- 7 April 2009
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (16) , 5760-5762
Selective Toxin Sequestrants for the Treatment of Bacterial Infections
Bacterial toxin-mediated diarrheal disease is a major cause of morbidity and mortality worldwide. In this work we designed an on-bead library of protease-resistant, acid-stable peptoid molecules and screened for high affinity binding of cholera toxin. From 100 000 compounds, we discovered a single sequence of residues that can bind and retain cholera toxin at high affinity when immobilized on a solid-phase particle. Furthermore, we demonstrate that these peptoid-displaying particles can sequester active cholera toxin from cell culture media sufficient to protect intestinal cells. We foresee this work as contributory to a potential adjunct therapeutic strategy against cholera infections and other toxin-mediated diseases.
- 7 April 2009
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (16) , 5760-5762
Selective Toxin Sequestrants for the Treatment of Bacterial Infections
Bacterial toxin-mediated diarrheal disease is a major cause of morbidity and mortality worldwide. In this work we designed an on-bead library of protease-resistant, acid-stable peptoid molecules and screened for high affinity binding of cholera toxin. From 100 000 compounds, we discovered a single sequence of residues that can bind and retain cholera toxin at high affinity when immobilized on a solid-phase particle. Furthermore, we demonstrate that these peptoid-displaying particles can sequester active cholera toxin from cell culture media sufficient to protect intestinal cells. We foresee this work as contributory to a potential adjunct therapeutic strategy against cholera infections and other toxin-mediated diseases.
- 1 November 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (22) , 5892-5894
The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues
- 1 November 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (22) , 5892-5894
The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues
- 16 October 2008
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 44,p. 5704-5706
Encoded combinatorial libraries for the construction of cyclic peptoid microarrays
A “one bead two compound” approach to the synthesis of encoded cyclic peptoid libraries is reported.
- 16 October 2008
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 44,p. 5704-5706
Encoded combinatorial libraries for the construction of cyclic peptoid microarrays
A “one bead two compound” approach to the synthesis of encoded cyclic peptoid libraries is reported.
- 26 August 2008
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 4 (11) , 1116-1125
Phosphorylation of the Gal4DNA-binding domain is essential for activator mono-ubiquitylation and efficient promoter occupancy
Recent analysis of a Gal4 mutant (Gap71) carrying three point mutations (S22D, K23Q and K25F) in its DNA-binding domain (DBD), has demonstrated that it cannot occupy GAL promoters efficiently in cells and that it is not mono-ubiquitylated, suggesting a functional link between this modification and stable DNA binding in cells. The mechanistic underpinning of this phenotype is that this protein is hypersensitive to a newly discovered activity of the proteasomal ATPases—their ability to actively dissociate transcription factor-DNA complexes after direct interaction with the activation domain. In this paper, we examine the roles of each of the three point mutations contained in Gap71 individually. These experiments have revealed that serine 22 is a site of phosphorylation in the Gal4 DBD and that lysine 23 is essential for S22 phosphorylation, possibly acting as part of the kinase recognition site. Mutation of either residue blocks Gal4 DBD phosphorylation, its subsequent ubiquitylation and compromises the ability of the activator to bind promoter DNA in vivo. These data represent the first report of an essential phosphorylation event that is critical for the activity of this paradigmatic transcription factor.
- 26 August 2008
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 4 (11) , 1116-1125
Phosphorylation of the Gal4DNA-binding domain is essential for activator mono-ubiquitylation and efficient promoter occupancy
Recent analysis of a Gal4 mutant (Gap71) carrying three point mutations (S22D, K23Q and K25F) in its DNA-binding domain (DBD), has demonstrated that it cannot occupy GAL promoters efficiently in cells and that it is not mono-ubiquitylated, suggesting a functional link between this modification and stable DNA binding in cells. The mechanistic underpinning of this phenotype is that this protein is hypersensitive to a newly discovered activity of the proteasomal ATPases—their ability to actively dissociate transcription factor-DNA complexes after direct interaction with the activation domain. In this paper, we examine the roles of each of the three point mutations contained in Gap71 individually. These experiments have revealed that serine 22 is a site of phosphorylation in the Gal4 DBD and that lysine 23 is essential for S22 phosphorylation, possibly acting as part of the kinase recognition site. Mutation of either residue blocks Gal4 DBD phosphorylation, its subsequent ubiquitylation and compromises the ability of the activator to bind promoter DNA in vivo. These data represent the first report of an essential phosphorylation event that is critical for the activity of this paradigmatic transcription factor.
- Open Access
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (31) , 21789-21798
Physical and Functional Interactions of Monoubiquitylated Transactivators with the Proteasome
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (31) , 21789-21798
Open AccessPhysical and Functional Interactions of Monoubiquitylated Transactivators with the Proteasome
- 4 July 2008
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 14 (3) , 223-227
A VEGFR2 Antagonist and Other Peptoids Evade Immune Recognition
- 4 July 2008
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 14 (3) , 223-227
A VEGFR2 Antagonist and Other Peptoids Evade Immune Recognition
- 11 June 2008
- Published by Springer Nature in Nature
- Vol. 453 (7197) , 861-862
Molecular cloaking devices
- 11 June 2008
- Published by Springer Nature in Nature
- Vol. 453 (7197) , 861-862
Molecular cloaking devices
- 1 June 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (12) , 6338-6343
A peptoid antagonist of VEGF Receptor 2 recognizes a ‘hotspot’ in the extracellular domain distinct from the hormone-binding site
- 1 June 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (12) , 6338-6343
A peptoid antagonist of VEGF Receptor 2 recognizes a ‘hotspot’ in the extracellular domain distinct from the hormone-binding site